- Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
- Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
- Edwards Lifesciences Reports Third Quarter Results
- CINDE Announces: Edwards Lifesciences Invests $100 million to Expand its Operations in Costa Rica
- Edwards Lifesciences To Host Earnings Conference Call On October 23, 2019
- Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients
Edwards Lifesciences Corp (EW:NYQ) closed at 238.98, -3.50% below its 52-week high of 247.64, set on Nov 19, 2019.
139.64Dec 24 2018247.64Nov 19 2019
Markit short selling activity
|Market cap||50.67bn USD|
|EPS (TTM)||3.86 |
Data delayed at least 15 minutes, as of Dec 06 2019 23:30 GMT.